METHODS OF TREATING HEMATOLOGIC CANCERS USING PNP INHIBITORS SUCH AS FORODESINE IN COMBINATION WITH ALKYLATING AGENTS OR ANTI-CD20 AGENTS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110038858A1
SERIAL NO

12747456

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOCRYST PHARMACEUTICALS INC4505 EMPEROR BLVD SUITE 200 DURHAM NC 27703

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Babu, Yarlagadda S Birmingham, US 104 1143
Bantia, Shanta Birmingham, US 36 184
Breitfeld, Philip Birmingham, US 5 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation